Publication

Prescribing Costs in Hospitals and the Community, England 2014/15

This is part of Prescribing Costs in Hospitals and the Community

Official statistics
Publication Date:
12 Nov 2015
Geographic Coverage:
England
Geographical Granularity:
Country, Regions
Date Range:
01 Apr 2014 to 31 Mar 2015

Summary

This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.

Key Facts

The overall NHS expenditure on medicines in 2014-15 was £15.5 billion, an increase of 7.8 per cent from £14.4 billion in 2013-14 and an increase of 19.4 per cent from £13.0 billion in 2010-11.

 

In 2014-15 hospital use accounted for 42.9 per cent of the total cost, up from 40.1 per cent in 2013-14 and up from 32.1 per cent in 2010/11.

 

The cost of medicines rose by 7.8 per cent overall but by 15.4 per cent in hospitals, from 2013-14 to 2014-15. The cost of medicines in hospitals has risen by 59.8 per cent since 2010-11.

 

Of the drugs positively appraised by NICE, the greatest overall cost in 2014-15 was for Adalimumab (£371.2m), which also incurred the greatest cost (over £348.2 million) in hospitals. 

Resources

Related Links